Jamie N. Anastas, Ph.D. - Publications

Affiliations: 
Molecular and Cellular Biology University of Washington, Seattle, Seattle, WA 
Area:
Wnt signaling

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Panditharatna E, G Marques J, Wang T, Trissal MC, Liu I, Jiang L, Beck A, Groves A, Dharia NV, Li D, Hoffman SE, Kugener G, Shaw ML, Mire HM, Hack OA, ... ... Anastas JN, et al. BAF complex maintains glioma stem cells in pediatric H3K27M-glioma. Cancer Discovery. PMID 36305736 DOI: 10.1158/2159-8290.CD-21-1491  0.458
2020 Jiao F, Li Z, He C, Xu W, Yang G, Liu T, Shen H, Cai J, Anastas JN, Mao Y, Yu Y, Lan F, Shi YG, Jones C, Xu Y, et al. RACK7 recognizes H3.3G34R mutation to suppress expression of MHC class II complex components and their delivery pathway in pediatric glioblastoma. Science Advances. 6: eaba2113. PMID 32832624 DOI: 10.1126/Sciadv.Aba2113  0.387
2019 Anastas JN, Zee BM, Kalin JH, Kim M, Guo R, Alexandrescu S, Blanco MA, Giera S, Gillespie SM, Das J, Wu M, Nocco S, Bonal DM, Nguyen QD, Suva ML, et al. Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG. Cancer Cell. PMID 31631026 DOI: 10.1016/J.Ccell.2019.09.005  0.652
2019 Anastas JN, Shi Y. Histone Serotonylation: Can the Brain Have "Happy" Chromatin? Molecular Cell. 74: 418-420. PMID 31051139 DOI: 10.1016/J.Molcel.2019.04.017  0.417
2017 Jambhekar A, Anastas JN, Shi Y. Histone Lysine Demethylase Inhibitors. Cold Spring Harbor Perspectives in Medicine. 7. PMID 28049654 DOI: 10.1101/Cshperspect.A026484  0.514
2014 Anastas JN, Kulikauskas RM, Tamir T, Rizos H, Long GV, von Euw EM, Yang PT, Chen HW, Haydu L, Toroni RA, Lucero OM, Chien AJ, Moon RT. WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors. The Journal of Clinical Investigation. 124: 2877-90. PMID 24865425 DOI: 10.1172/Jci70156  0.546
2013 Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer. Nature Reviews. Cancer. 13: 11-26. PMID 23258168 DOI: 10.1038/Nrc3419  0.597
2012 Yang PT, Anastas JN, Toroni RA, Shinohara MM, Goodson JM, Bosserhoff AK, Chien AJ, Moon RT. WLS inhibits melanoma cell proliferation through the β-catenin signalling pathway and induces spontaneous metastasis. Embo Molecular Medicine. 4: 1294-307. PMID 23129487 DOI: 10.1002/Emmm.201201486  0.591
2012 Anastas JN, Biechele TL, Robitaille M, Muster J, Allison KH, Angers S, Moon RT. A protein complex of SCRIB, NOS1AP and VANGL1 regulates cell polarity and migration, and is associated with breast cancer progression. Oncogene. 31: 3696-708. PMID 22179838 DOI: 10.1038/Onc.2011.528  0.622
2011 Berndt JD, Aoyagi A, Yang P, Anastas JN, Tang L, Moon RT. Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. The Journal of Cell Biology. 194: 737-50. PMID 21875946 DOI: 10.1083/Jcb.201107021  0.554
2008 Major MB, Roberts BS, Berndt JD, Marine S, Anastas J, Chung N, Ferrer M, Yi X, Stoick-Cooper CL, von Haller PD, Kategaya L, Chien A, Angers S, MacCoss M, Cleary MA, et al. New regulators of Wnt/beta-catenin signaling revealed by integrative molecular screening. Science Signaling. 1: ra12. PMID 19001663 DOI: 10.1126/Scisignal.2000037  0.568
Show low-probability matches.